Table 4. Stability of PQ. Data represent mean (± SD).
Conditions | Untreated*** | treated | % remained | n |
---|---|---|---|---|
Plasma, glass container, 4°C, 16 hr | ||||
30 ng/mL | 29.8±2.3 | 30.2±1.1 | 101 | 3 |
800 ng/mL | 796±4 | 832±14 | 105 | 3 |
Autosampler plastic vials, 21–25°C, 7 days | ||||
30 ng/mL | 32.8±1.7 | 29.4±1.1 | 89.6 | 4 |
800 ng/mL | 865±27 | 857±19 | 99.1 | 4 |
Five freeze-thaw cycles | ||||
30 ng/mL | 31.7±1.3 | 30.9±1.2 | 97.5 | 3 |
800 ng/mL | 844±12 | 843±12 | 99.9 | 3 |
Plasma, -70°C, 21 months* | ||||
3 ng/mL | 2.76±0.15 | 2.78±0.04 | 101 | 3 |
200 ng/mL | 200±6 | 209±5 | 104 | 3 |
Stock, -70°C, 40 months** | ||||
8170±605 | 8091±338 | 99 | 3 |
* Measured with our previously published method
**measured with UPLC-PDA with peek tubing injection needle.
*** untreated samples were prepared fresh in plastic vials.